×
Masimo Common Stock Net 2010-2024 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo common stock net for the quarter ending December 31, 2024 was
$0.000B
, a
0% increase
year-over-year.
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2024.
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Masimo common stock net for 2023 was
$0B
, a
0% decline
from 2023.
View More
Masimo Common Stock Net 2010-2024 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2024.
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Masimo common stock net for 2023 was
$0B
, a
0% decline
from 2023.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216.7B
Thermo Fisher Scientific (TMO)
$203.1B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44B
IDEXX Laboratories (IDXX)
$36.9B
DexCom (DXCM)
$35B
IQVIA Holdings (IQV)
$34.6B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.4B
STERIS (STE)
$21.8B
SONOVA HOLDING (SONVY)
$19.6B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.6B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Glaukos (GKOS)
$8.9B
Teleflex (TFX)
$8.1B
Integer Holdings (ITGR)
$4.8B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.5B
Veracyte (VCYT)
$3.3B
Nihon Kohden (NHNKY)
$2.7B
TransMedics (TMDX)
$2.7B
LivaNova (LIVN)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B
Pulse Biosciences (PLSE)
$1.2B